Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOGAD) research hub

A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-associated Disease (MOGAD)

This study is looking at a new medicine called rozanolixizumab for adults with a rare condition called MOGAD. We want to see if it's safe and helps improve symptoms or stop flare-ups of the condition.